DAFNA Capital Management »

Inspire Med Sys shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Inspire Med Sys (INSP) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Inspire Med Sys

Tip: Access up to 7 years of quarterly data

All positions including Inspire Med Sys held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inspire Med Sys by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 17k 74.20

More positions owned by DAFNA Capital Management

Stereotaxis Com New (STXS)
Spdr S&p Biotech Etf Etf (XBI)
Revolution Medicines (RVMD)
Cytokinetics Com New (CYTK)
AtriCure (ATRC)
Merus N V (MRUS)
Ishares Nasdaq Biotech Indx Etf (IBB)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Xenon Pharmaceuticals (XENE)
Neurocrine Biosciences (NBIX)
Arcus Biosciences Incorporated (RCUS)
Syndax Pharmaceuticals (SNDX)
Day One Biopharmaceuticals I (DAWN)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for DAFNA Capital Management

Top funds holding Inspire Med Sys

BlackRock
Vanguard Group
Citadel Advisors
William Blair Investment Management
Baillie Gifford & Co
Deerfield Management Company
State Street Corporation
Braidwell
Ubs Global Asset Management Americas
FMR
Soleus Capital Management
Henderson Group
Balyasny Asset Management
Artisan Partners Limited Partnership
Bnp Paribas Arbitrage, Snc

View all funds holding Inspire Med Sys